A Novel TanCAR Targeting IL13Rα2 and EphA2 for Enhanced Glioblastoma Therapy

To improve CAR-T therapy for glioblastoma, a new TanCAR, comprising the tandem arrangement of IL13 and EphA2 scFv, was generated and validated in vitro and in vivo.